Institutional Ownership
Beta Bionics Inc
CUSIP 08659B102COMBBNXQ1 2026
13D / 13G Filings
25
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
11.3%
Max % of class reported
Institutional Holders
126
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
25 filings · latest Feb 23, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 23, 2026 | Point72 Asset Management, L.P. | 13G | 5.2% | 2.29M | SEC |
| 2 | Feb 17, 2026 | Rtw Investments, LP | 13G/A | 5.7% | 2.50M | SEC |
| 3 | Feb 12, 2026 | Soleus Bb Spv, LLC | 13G/A | 5.8% | 2.53M | SEC |
| 4 | Feb 10, 2026 | Wellington Hadley Harbor Aggregator IV, L.P. | 13G/A | — | — | SEC |
| 5 | Feb 10, 2026 | Wellington Management Group LLP | 13G/A | — | 9 | SEC |
| 6 | Feb 9, 2026 | Zone Healthcare Holdings, LLC | 13G/A | 9.9% | 4.38M | SEC |
| 7 | Nov 12, 2025 | Zone Healthcare Holdings, LLC | 13G/A | 9.9% | 4.31M | SEC |
| 8 | Nov 7, 2025 | Morgan Stanley | 13G/A | 8.6% | 3.74M | SEC |
| 9 | Oct 30, 2025 | The Vanguard Group | 13G | 5.1% | 2.22M | SEC |
| 10 | Oct 17, 2025 | Blackrock, Inc. | 13G | 6.4% | 2.78M | SEC |
15 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Beta Bionics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Eventide Asset Management, LLC | 5.95M | $59.57M |
| 2 | Soleus Capital Management, L.P. | 4.35M | $43.63M |
| 3 | Morgan Stanley | 4.23M | $42.36M |
| 4 | Sands Capital Alternatives, LLC | 3.71M | $37.15M |
| 5 | Farallon Capital Management LLC | 3.61M | $36.15M |
| 6 | Blackrock, Inc. | 3.04M | $30.45M |
| 7 | Point72 Asset Management, L.P. | 2.53M | $25.30M |
| 8 | Vestal Point Capital, LP | 2.21M | $22.16M |
| 9 | Rtw Investments, LP | 2.00M | $20.04M |
| 10 | Eversept Partners, LP | 1.41M | $14.18M |